BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1589 related articles for article (PubMed ID: 17576399)

  • 1. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
    Nguyên-Pascal ML; Thomas JL; Bergougnoux L; Garnero P; Drapier-Faure E; Delmas PD
    Climacteric; 2005 Jun; 8(2):136-45. PubMed ID: 16096169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of nomegestrol acetate administered alone or with cutaneous 17 beta estradiol in inversed sequence on cycle quality and hot flashes in periomenopausal women].
    Zartarian M; Micheletti MC; Gauthier A; Torres C; Dewailly D
    Contracept Fertil Sex; 1998 Jan; 26(1):69-76. PubMed ID: 9532886
    [No Abstract]   [Full Text] [Related]  

  • 5. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC; Coutinho EM; Oladapo L; Noronha CF; Mota RL; Lopes AC; Lopes RC
    Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
    Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
    Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of nomegestrol acetate on the improvement of the quality of life induced by estrogen therapy in menopausal women].
    Reginster JY; Zartarian M; Colau JC
    Contracept Fertil Sex; 1996 Nov; 24(11):847-51. PubMed ID: 8991589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-dose estrogens in the treatment of the climacteric syndrome].
    Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
    Szántó F
    Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transdermal administration of estrogens in women with the postcastration and climacteric syndromes].
    Rotta L; Matĕchová E
    Cesk Gynekol; 1992 Sep; 57(7):336-40. PubMed ID: 1394497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
    Bassol S; Carranza-Lira S; Celis-Gonzalez C; Santoyo S; Murillo A; Martinez N; Santos J; Llaca V; de la Loza FR; Zarain J; da Fonseca AM; Camargos AF; Baracat EC; da Sá MF; Bayo J; Adaro L; Gurucharri C; Murga M; Siseles N; Sayegh F; Tempone A; Tempone LM; Tozzini RI; Boccanera R; Naranjo C; Sanchez F; Gomez G; Blanco S; Reyes-Marquez R; Albrecht G; Rios PC
    Maturitas; 2005 Mar; 50(3):189-95. PubMed ID: 15734600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of hormonal therapy in menopausal kidney-allograft recipients.
    Pietrzak B; Cyganek A; Jabiry-Zieniewicz Z; Bobrowska K; Durlik M; Ołdakowska-Jedynak U; Bińkowska M; Paczek L; Kamiński P
    Transplant Proc; 2006; 38(1):184-7. PubMed ID: 16504698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
    Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
    J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression].
    Yazici K; Pata O; Yazici A; Aktaş A; Tot S; Kanik A
    Turk Psikiyatri Derg; 2003; 14(2):101-5. PubMed ID: 12844276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of the association of Kava-Kava extract and hormone replacement therapy in the treatment of postmenopause anxiety].
    De Leo V; La Marca A; Lanzetta D; Palazzi S; Torricelli M; Facchini C; Morgante G
    Minerva Ginecol; 2000 Jun; 52(6):263-7. PubMed ID: 11085051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study].
    Drapier-Faure E; Azoulay C; Abramovici Y
    Gynecol Obstet Fertil; 2005; 33(7-8):498-504. PubMed ID: 16005674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
    Prázný M; Fait T; Vrablik M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.